Ilyda

Athens, Greece Founded: 1992 • Age: 34 yrs Listed
ERP and software solutions are provided for retail businesses.

About Ilyda

Ilyda is a publicly listed company based in Athens (Greece) founded in 1992. ERP and software solutions are provided for retail businesses. It operates in the Technology and Retail sectors. Ilyda offers products and services including MegaTron ERP, MegaTron Pharma ERP, Dioscourides, UniTron, and LIS Bio-Diagnosis. Its focus areas include Enterprise Applications, Enterprise Resource Planning, Suite and In Store Retail Tech. Its legal entity is ILYDA A.E.

Company details

Provider of ERP software for retail businesses. The company offers Megatron ERP suite which includes modules such as WMS, production, project management, costing, customers-suppliers, orders purchasing and sales, buying selling, cash management, MIS, general analytical accounting, budget report, and HRMS. The company also offers KiniTron Smart ERP for wholesale or retail sectors and software for specialized vertical markets, which targets pharmacies and points of sale programs for retail chains of stores.

Key Metrics
  • Annual Revenue
    $10.58 M (USD)
    26.41
    as on Dec 31, 2025
  • Net Profit
    $5.21 M (USD)
    15.93
    as on Dec 31, 2025
  • EBITDA
    $8.03 M (USD)
    32.45
    as on Dec 31, 2025
  • Investors

Products & Services of Ilyda

Ilyda offers a comprehensive portfolio of products and services, including MegaTron ERP, MegaTron Pharma ERP, Dioscourides, UniTron, and LIS Bio-Diagnosis.

MegaTron ERP
ERP System

Integrated platform for enterprise resource management and optimization.

MegaTron Pharma ERP
Specialized ERP

Tailored system for pharmaceutical inventory and operations management.

Dioscourides
Healthcare Software

Program for pharmacy management and counterfeit drug prevention.

UniTron
Education Software

System for student information and university administration tasks.

LIS Bio-Diagnosis
Diagnostic Software

Tool for managing microbiological labs and medical diagnostics.

Funding Insights of Ilyda

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Ilyda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2010Debt – Venture––
Valuation history

1 investors in total: 1 institutional.

Investors in Ilyda

Ilyda has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Global Emerging Markets.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by this private equity firm.
gemny.comNew York, United States
Premium access

Investor details for Ilyda

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of Ilyda

Ilyda is a publicly listed company on the ATHEX with ticker symbol ILYDA in Greece, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date26 Feb 2004
  • Listed onATHEX: ILYDA
  • Listed entityILYDA S.A.
  • Exchange sectorTechnology services
  • ISINGRS475003018
  • Share price4.19 EUR (+0.72% on the day) · 2026-10-14
  • Market capitalisation58,702,583.00 EUR
  • Dividend yield2.16%
  • Volume (last session)3,625

Financials of Ilyda

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20259.0M EUR4.4M EUR6.8M EUR
20247.1M EUR3.8M EUR5.2M EUR
20234.1M EUR1.1M EUR1.8M EUR
20224.3M EUR1.3M EUR1.5M EUR
20214.4M EUR429,950 EUR1.8M EUR
Premium access

Detailed financial statements for Ilyda

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Ilyda

3 dated milestones of Ilyda across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ilyda is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round.

Web traffic of Ilyda

The website of Ilyda (ilyda.com) receives about 6.7K visits a month and ranks #3,039,655 among all websites worldwide, #3,660 in Pharmacy.

  • Monthly visits
    6.7K

    ▼ 9.4% vs previous month

  • Unique visitors
    3.6K

    per month

  • Global rank
    #3,039,655

    among all websites

  • Category rank
    #3,660

    Health · Pharmacy

Similar websites

Websites whose visitors overlap most with Ilyda. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pharmateam.blogspot.gr
pharmateam.blogspot.gr
100%
–
fsth.gr
fsth.gr
99%
#489,949–
pfs.gr
pfs.gr
92%
#1,219,970–
unitron.com
65%
#476,253View details
eof.gr
eof.gr
62%
#608,501–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Ilyda

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ilyda

Premium access

Complete news archive for Ilyda

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ilyda

Ilyda was founded in 1992 and raised its 1st funding round 18 years after it was founded.

Ilyda is headquartered in Athens, Greece.

Annual revenue of Ilyda is $10.58M as on Dec 31, 2025.

Provider of ERP software for retail businesses. The company offers Megatron ERP suite which includes modules such as WMS, production, project management, costing, customers-suppliers, orders purchasing and sales, buying selling, cash management, MIS, general analytical accounting, budget report, and HRMS. The company also offers KiniTron Smart ERP for wholesale or retail sectors and software for specialized vertical markets, which targets pharmacies and points of sale programs for retail chains of stores.

Ilyda offers MegaTron ERP, MegaTron Pharma ERP, Dioscourides, UniTron, and LIS Bio-Diagnosis.

Yes, Ilyda is publicly traded on ATHEX under the ticker symbol ILYDA.

Ilyda has 1 investor. Key investors include Global Emerging Markets.

Ilyda operates through Ilyda A.E..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available